Détail de l'auteur
Documents disponibles écrits par cet auteur (291)
Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018.[...]Rapport
Rapport
The trafficking of drugs and, in particular, the use of human carriers (often called 'drug mules') remains a relatively hidden phenomenon, on which limited information is available. This latest EMCDDA Thematic paper explores whether a common def[...]Chapitre
FRANÇAIS : La stratégie antidrogue de l'Union européenne (2000-2004) stipule que le Conseil et la Commission européenne devraient tenter de dresser une liste détaillée de toutes les dépenses publiques dans le domaine de la lutte contre la drogu[...]Rapport
This paper presents the EMCDDA's current thinking on the conceptual framework for monitoring drug markets, crime and supply reduction - building on the work completed in this area and expanding to reflect the academic research underpinning this [...]Rapport
OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2019ENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]Rapport
OEDT = EMCDDA ; H. SCHULZE, Coordonnateur ; M. SCHUMACHER ; R. URMEEW ; K. AUERBACH ; J. ALVAREZ ; I. M. BERNHOFT ; H. DE GIER ; M. HAGENZIEKER ; S. HOUWING ; A. KNOCHE ; B. PILGERSTORFER ; B. ZLENDER ; B. HUGHES ; L. VANDAM | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This Thematic paper presents the key findings of the European Union’s research project on Driving Under the Influence of Drugs, Alcohol and Medicines, known as the DRUID project. The project looked at experimental studies, epidemiological studie[...]Rapport
A main aim of this report is to inform discussions on drug consumption rooms (DCRs) by examining the available evidence, as well as reviewing the various models being adopted and their characteristics. The report is based on a mixed-methods app[...]Rapport
One of the targets of the EU action plan is 'to reduce significantly over five years the prevalence of drug use, as well as new recruitment to it, particularly among young people under 18 years of age'. In total there are eight references to you[...]Rapport
FRANÇAIS : Les peines prononcées à l'encontre des délinquants pour des infractions liées à la drogue à travers l'Union européenne sont examinées pour la première fois dans la présente «Question spécifique». En analysant les statistiques les pl[...]Rapport
OEDT = EMCDDA ; A. O'GORMAN ; E. QUIGLEY ; F. ZOBEL ; K. MOORE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013This study explores the civil society organisations that engage in drug policy advocacy in Europe. An Internet search in English, French and Spanish combined with information from national sources in 30 countries identified 218 organisations act[...]Rapport
This paper describes the development and main characteristics of drug policy in Austria. It traces the development of Austrian drug laws from the time of the Austro-Hungarian Empire through to the present day. Austria's drug policy has several d[...]Rapport
This paper describes the development and main characteristics of drug policy in Poland. It starts with the early days of drug control in Poland in the 1920s, describes the changes related to the emergence of Polish heroin - Kompot - in the late [...]Rapport
OEDT = EMCDDA ; E. QUIGLEY ; B. HUGHES ; C. COSTA STORTI ; F. ZOBEL | Lisbon : OEDT / EMCDDA | Drug policy profiles, ISSN 1977-2246 | 2013The national drug policy of Ireland comes under the spotlight in the second volume in the EMCDDA series of Drug policy profiles. Examining the evolution of Irish drug policy through four periods of historic development, the report explores: the [...]Rapport
This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU. This includes describing the 'pre-precursor' phenomenon and r[...]Rapport
This report considers substance use prevention in Europe through the lens of a system, highlighting the wide range of factors that need to be addressed to successfully implement substance use prevention programmes and policies. They are consider[...]Rapport
This Thematic paper contains the results of a study that examined drug prevention interventions for minority ethnic populations in 29 European countries. A total of 33 interventions were reported to the study and the issues they raise are presen[...]Rapport
This publication provides an update on drug-related deaths in Europe, presenting and analysing the latest data and trends in drug-induced deaths and overall mortality among high-risk drug users in the European Union and beyond. It draws on contr[...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; F. MATHIS ; D. HEDRICH ; J. VICENTE ; A. NOOR | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deat[...]Rapport
This report is part of the EMCDDA activity around the development and improvement of drug supply indicators, which are designed to reflect developments in drug markets as well as the markets' wider harms and impact. The protocol in this document[...]Rapport
Homicide is a violent act that generates high social costs. In particular, drug-related homicide (DRH) has the potential to act as an indicator of wider drug-related crime. Comparing DRH levels between countries with data on this topic can be a [...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; A. M. DINES ; N. SINGLETON ; A. NOOR ; P. I. DARGAN ; D. WOOD | Lisbon : OEDT / EMCDDA | Technical reports | 2020ENGLISH: This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of th[...]Rapport
This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020, while high[...]Rapport
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and[...]Rapport
An update on the EMCDDA 2008 Selected Issue on drug-related research, this thematic paper identifies current and future challenges and opportunities for drug-related research in Europe.Rapport
OEDT = EMCDDA ; L. LANIEL ; R. KASECKER ; T. GROSHKOVA ; C. CARPENTIER | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013Drug law enforcement activity targets the supply of drugs and is responsible for much of the key data that informs our understanding of drugs supply in Europe. This study looks, for the first time, at how drug law enforcement is organised in Eur[...]Rapport
OEDT = EMCDDA ; L. LANIEL ; T. SURMONT ; T. STOIAN ; S. ALM | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2017In 2014, the EMCDDA took the decision to carry out a limited follow-up study of the EMCDDA Paper Drug squads: units specialised in drug law enforcement in Europe (EMCDDA, 2013), with the aim of monitoring possible changes and trends in drug supp[...]Rapport
OEDT = EMCDDA ; E. QUIGLEY ; R. SEDEFOV ; C. CARPENTIER ; L. LANIEL ; European Commission, COWI Consortium for DG Health and Consumers | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013The production and trafficking of illicit drugs poses complex and interlinked problems, which have a negative impact on public health and the security and stability of society. Focusing on actions directed at the EU's internal security situation[...]Rapport
OEDT = EMCDDA ; L. AMATO ; Z. MITROVA ; M. DAVOLI | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2017Although rare, drug testing in schools continues to be practised in some European countries. In many cases, drug testing is intended to act as a deterrent to substance use. Nevertheless, studies conducted in the United States show that the drug [...]Rapport
OEDT = EMCDDA ; R. KERT ; A. LEHNER ; B. HUGHES ; O. DALBINOE | Lisbon : OEDT / EMCDDA | Technical reports | 2017The results of a study on national drug trafficking laws and their application in the Member States of the European Union are presented in this report. It is based on an analysis of the national laws and on the opinions of legal practitioners - [...]Rapport
It is estimated that over 1 million people receive treatment for drug-related problems in the European Union every year. With shrinking public budgets, increasing pressure on health systems, changes in the drugs used and the need to provide on-g[...]Rapport
This report presents a summary of the key findings from drug treatment facility surveys carried out in 2017 in Albania, Bosnia and Herzegovina, Serbia and the territory of Kosovo. The results provide insight into the characteristics and capacity[...]Rapport
The result of the EMCDDA's cooperation with countries in the Western Balkans over many years, this report is the first of its kind. It gives insight into the drug-related problems faced by six countries in the region, through the available data [...]Rapport
OEDT = EMCDDA ; L. ROYUELA ; L. MONTANARI ; M. ROSA ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014The report presents a review of tools for monitoring illicit drug use in prison population in Europe. The objective of the report is to describe the existing tools used at national level, to assess their comparability and to build a common Europ[...]Rapport
Drug use is directly or indirectly prohibited in all EU countries - except for in medical or scientific circumstances - and punishment for offences varies from administrative to penal, depending on the country. This thematic paper analyses curre[...]Rapport
This joint report prepared by the EMCDDA and Europol considers the latest findings from international research, fresh empirical data, and operational information and intelligence in order to illuminate how darknet markets function and how they r[...]Rapport
FRANÇAIS : La politique sociale en Europe a depuis longtemps identifié les populations défavorisées qui courent un risque d'exclusion sociale. Ces «groupes vulnérables» désignent des groupes spécifiques au sein de la population, qui sont plus [...]Rapport
OEDT = EMCDDA ; K. SKARUPOVA ; T. NÉFAU ; E. LEFRANÇOIS ; T. SEYLER | Lisbon : OEDT / EMCDDA | Rapid communication | 2019This report presents the results of an innovative method for gathering information on the substances used by people who inject drugs. In this pilot study, chemical analysis of the contents of used syringes collected from exchange sites reveals t[...]Rapport
FRANÇAIS : Les problèmes liés à la drogue apparaissent souvent - et sont ressentis de la façon la plus aiguë - dans les environnements urbains, ce qui fait des villes d'Europe une précieuse fenêtre d'observation sur les nouvelles tendances du p[...]Rapport
Since the late 1990s, drug strategies and action plans have been increasingly adopted by EU countries as the central instrument for implementing drug policy. This thematic paper looks at the origins and characteristics of this phenomenon as well[...]Rapport
OEDT = EMCDDA ; A. GALLEGOS ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This publication presents 30 profiles of the national early warning systems on new psychoactive substances in operation in Europe in 2011. The early warning system on new psychoactive substances is a multidisciplinary network consisting of 30 Eu[...]Rapport
European Centre for Disease Prevention and Control ; OEDT = EMCDDA | Lisbon : OEDT / EMCDDA | Joint publications | 2011FRANÇAIS : Sept interventions, un objectif : zéro infections parmi les personnes qui s’injectent des drogues. Dans un nouveau rapport d'orientation publié aujourd'hui, deux agences de l'UE, l'ECDC et l'OEDT, ont uni leurs efforts pour recenser [...]Congrès
The conference "Identifying Europes information needs for effective drug policy" marked the 15th anniversary of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), and our activity of monitoring drugs and drug addiction in the [...]Rapport
FRANÇAIS : De nouvelles substances psychoactives deviennent largement disponibles à un « rythme sans précédent ». En 2010, un nombre record de nouvelles drogues ont été officiellement signalées à l'OEDT et à Europol par le biais du système d'al[...]Rapport
FRANÇAIS : De nouvelles drogues ont été détectées dans l'Union européenne l'année dernière, à raison d'une par semaine environ, selon le rapport annuel conjoint de l'OEDT et d'Europol (2011) sur les nouvelles substances psychoactives publié auj[...]Rapport
FRANÇAIS : Le rapport annuel 2013 OEDT-Europol, qui fait le point sur les nouvelles drogues, indique que le nombre, le type et la disponibilité des nouvelles drogues en Europe ont continué à croître en 2012. Elles étaient au nombre de 49 en 201[...]Rapport
This report presents the key activities performed by the EMCDDA and Europol in 2013, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and c[...]